A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/50 (2006.01) A61K 45/06 (2006.01) A61K 47/48 (2006.01) A61P 31/14 (2006.01) A61P 35/00 (2006.01) C12Q 1/70 (2006.01)
Patent
CA 2506244
The present invention is directed to methods of modulating viral replication in vivo comprising administering to an individual a therapeutically or prophylactically effective amount of a composition comprising arginine deiminase modified with polyethylene glycol, to methods of concurrently modulating viral replication and treating cancer, and to methods of modulating nitric oxide levels in a patient, among others.
La présente invention se rapporte à des méthodes de modulation d'une réplication virale in vivo, qui consistent à administrer à un sujet une quantité efficace d'un point de vue thérapeutique ou prophylactique d'une composition comportant de l'arginine déiminase modifiée par du polyéthylène glycol. L'invention se rapporte également à des méthodes permettant simultanément de moduler une réplication virale et de traiter un cancer, ainsi qu'à des méthodes de modulation, entre autres, des taux de monoxyde d'azote chez un patient.
Phoenix Pharmacologics Inc.
Polaris Group
Smart & Biggar
LandOfFree
Methods for inhibiting viral replication in vivo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting viral replication in vivo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting viral replication in vivo will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1371695